VEGFA and neoplasm: In the tumor microenvironment, secretion of TSP-1 by activated stromal cells including fibroblasts inhibits primary tumor growth and invasiveness by inhibiting MMP9 and therefore the release of VEGF from extracellular matrix or by binding to CD36 on the surface of endothelial cells and promoting apoptosis3,18,30.